复发性卵巢癌的每周铂类化疗。
Weekly platinum chemotherapy for recurrent ovarian cancer.
作者信息
Clamp A, Jayson G C
出版信息
Br J Cancer. 2002 Jan 7;86(1):2-4. doi: 10.1038/sj.bjc.6600062.
Abstract
(2002) , 2–4. DOI: 10.1038/sj/bjc/6600062 www.bjcancer.com © 2002 The Cancer Research Campaign
摘要
（2002年），第2 - 4页。DOI：10.1038/sj/bjc/6600062 www.bjcancer.com ©2002年癌症研究运动组织
相似文献
1
Weekly platinum chemotherapy for recurrent ovarian cancer.
Br J Cancer. 2002 Jan 7;86(1):2-4. doi: 10.1038/sj.bjc.6600062.
2
Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer.
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):228-34. doi: 10.1111/j.1525-1438.2007.00994.x. Epub 2007 May 19.
3
Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity.
Eur J Cancer. 2002 Feb;38(3):387-91. doi: 10.1016/s0959-8049(01)00381-1.
4
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.
Ann Oncol. 1994 Sep;5(7):656-7. doi: 10.1093/oxfordjournals.annonc.a058942.
5
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer.
Ann Oncol. 2001 Dec;12(12):1705-9. doi: 10.1023/a:1013558501425.
6
Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer.
Br J Cancer. 2002 Jan 7;86(1):19-25. doi: 10.1038/sj.bjc.6600002.
7
Feasibility of extension of platinum-free interval with weekly bolus topotecan and subsequent platinum retreatment outcomes in recurrent ovarian cancer.
Arch Gynecol Obstet. 2011 Feb;283(2):361-7. doi: 10.1007/s00404-010-1462-9. Epub 2010 Apr 11.
8
Treatment for recurrent ovarian cancer. A report of 2 cases.
S Afr Med J. 1987 Feb 7;71(3):180.
9
Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy.
Eur J Gynaecol Oncol. 1997;18(1):44-6.
10
[Treatment of recurrent ovarian cancer].
Gan To Kagaku Ryoho. 1992 Oct;19(12):1991-7.
本文引用的文献
1
Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer.
Br J Cancer. 2002 Jan 7;86(1):19-25. doi: 10.1038/sj.bjc.6600002.
2
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer.
Ann Oncol. 2001 Dec;12(12):1705-9. doi: 10.1023/a:1013558501425.
3
Phase II study of prolonged oral etoposide in refractory ovarian cancer.
Int J Gynecol Cancer. 1995 Sep;5(5):351-354. doi: 10.1046/j.1525-1438.1995.05050351.x.
4
Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy.
Gynecol Oncol. 2000 Nov;79(2):211-5. doi: 10.1006/gyno.2000.5958.
5
Topoisomerase II inhibitor-related acute myeloid leukaemia.
Br J Haematol. 2000 Apr;109(1):13-23. doi: 10.1046/j.1365-2141.2000.01843.x.
6
Docetaxel administered on a weekly basis for metastatic breast cancer.
J Clin Oncol. 2000 Mar;18(6):1212-9. doi: 10.1200/JCO.2000.18.6.1212.
7
Mature results of a prospective randomized trial comparing a three-weekly with an accelerated weekly schedule of cisplatin in advanced ovarian carcinoma.
Am J Clin Oncol. 1999 Dec;22(6):559-67. doi: 10.1097/00000421-199912000-00005.
8
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
J Clin Oncol. 1998 Feb;16(2):405-10. doi: 10.1200/JCO.1998.16.2.405.
9
Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [seecomments].
Ann Oncol. 1997 Oct;8(10):963-8. doi: 10.1023/a:1008240421028.
10
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.
J Clin Oncol. 1997 May;15(5):1938-44. doi: 10.1200/JCO.1997.15.5.1938.
Zotero 插件